New York, March 23, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Laser BPH Devices Market Size, Share & Industry Trends Analysis Report By End User, By ...
Laser Prostatectomy for BPH On the Rise From 2001-2009, the procedure replaced nearly 50% of transurethral resections of the prostate. Laser prostatectomy use has increased substantially as a ...
April 4, 2003 — Interstitial laser coagulation (ILC) may be a viable alternative to standard transurethral resection of the prostate (TURP), according to the results of a multicenter, randomized trial ...
BPH is the fifth most prevalent non-cancer disorder among men 50 years and older (Rev Urol. 2006;8 [Suppl 3]:S9-S15). Office visits for BPH increased from 10,116 per 100,000 patients in 1994 to 14,473 ...
The application of lasers for the treatment of benign prostatic hyperplasia has evolved over the past 15 years. Early-generation neodymium: yttrium aluminum garnet lasers were used to coagulate and ...
May 1, 2003 (Chicago) -- For the treatment of benign prostatic hyperplasia (BPH), interstitial laser coagulation (ILC) appears to be similar in efficacy and safety to standard transurethral resection ...
TURP Device Sales in Spain, France and the U.K. Drive Growth in the BPH Treatment Market VANCOUVER, April 24, 2012 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), ...
The introduction of laser therapies for the management of bladder outlet obstruction in men with BPH has challenged the gold standard treatment, TURP. We sought to compare the changing clinical ...
Surge in the prevalence of benign prostatic hyperplasia, rise in the incidence of obesity and diabetes, and increase in the geriatric population drive the growth of the global laser BPH devices market ...
Analytical depiction of the global Laser BPH Devices industry along with the current trends and future estimations to determine the imminent investment pockets. PORTLAND, OREGON, US, August 12, 2022 ...
Benign prostatic hyperplasia is a non-cancerous enlargement of the prostate. It can block or narrow the tube that urine passes through to leave the body (urethra), which can cause lower urinary tract ...